HF
WST icon

HRT Financial’s West Pharmaceutical WST Stock Holding History

HRT Financial’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-127,188
Closed -$35M – 4860
2025
Q4 		$35M Buy
127,188
+124,799
+5,224% +$34.1M 0.11% 127
2025
Q3 		$626K Sell
2,389
-58,414
-96% -$14.2M ﹤0.01% 1761
2025
Q2 		$13.3M Buy
+60,803
New +$13M 0.06% 237
2024
Q4 		– Sell
-26,481
Closed -$7.95M – 3357
2024
Q3 		$7.95M Buy
26,481
+13,966
+112% +$4.28M 0.04% 286
2024
Q2 		$4.12M Buy
12,515
+4,818
+63% +$1.7M 0.02% 456
2024
Q1 		$3.04M Sell
7,697
-9,209
-54% -$3.41M 0.02% 412
2023
Q4 		$5.95M Buy
16,906
+16,031
+1,832% +$5.67M 0.04% 250
2023
Q3 		$328K Buy
+875
New +$338K ﹤0.01% 1617
2023
Q2 		– Sell
-38,726
Closed -$13.4M – 3390
2023
Q1 		$13.4M Buy
38,726
+27,240
+237% +$7.96M 0.16% 99
2022
Q4 		$2.7M Sell
11,486
-4,282
-27% -$1.01M 0.04% 462
2022
Q3 		$3.88M Buy
+15,768
New +$4.8M 0.04% 373
2022
Q2 		– Sell
-8,882
Closed -$3.65M – 3842
2022
Q1 		$3.65M Buy
+8,882
New +$3.48M 0.03% 381
2021
Q3 		– Sell
-7,261
Closed -$2.61M – 3829
2021
Q2 		$2.61M Buy
+7,261
New +$2.4M 0.02% 512
2020
Q4 		– Sell
-2,549
Closed -$700K – 2545
2020
Q3 		$700K Buy
+2,549
New +$675K 0.02% 728
2020
Q2 		– Sell
-3,137
Closed -$477K – 1793
2020
Q1 		$477K Buy
+3,137
New +$483K 0.03% 396
2019
Q4 		– Sell
-6,000
Closed -$850K – 1712
2019
Q3 		$850K Buy
+6,000
New +$826K 0.04% 432
2018
Q2 		– Sell
-10,600
Closed -$935K – 379
2018
Q1 		$935K Buy
+10,600
New +$992K 0.45% 51

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HRT Financial's WST Position: Q1 2026 in Review

HRT Financial sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 127,188 shares — an estimated $35M sold.

HRT Financial first reported a position in WST in Q1 2018 and held it in 17 quarters. The position peaked at $35M in Q4 2025. 754 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • HRT Financial reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 127,188 West Pharmaceutical shares in Q1 2026, an estimated $35M.
  • HRT Financial first reported a position in West Pharmaceutical in Q1 2018 and held it in 17 quarters.
  • HRT Financial's West Pharmaceutical position peaked at $35M in Q4 2025.
  • 754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.